ROUND TABLE · 2017

2017 – Biodrugs regulation & control

Biodrugs regulation & control

2017-bio-drugs-5e5ba4ca

About this session

Set up a work team to develop the necessary guidelines and skills required

Take inspiration from international guidelines (FDA / EMA) and adapt it to the realities of the Algerian market

The need for commitment and training of all stakeholders: governments, companies, practitioners, pharmacists, patient groups

Attending experts

Dr-purnima-Sharma-1cb1a0e0

Dr. Purnima Sharma

BCIL India

PR-ruth-bf19042f

Pr. Ruth Lopert

Dr.-Valderilio-Azevedo-ffefa2d4

Dr. Valderilio Azevedo

EDUMED

Audience

  • Director General of Pharmacy, MOH, Dr. Hamou Hafed
  • General Manager of PCH, M’hamed Ayad
  • Director General of Social Security, Djaouad Bourkaib & Dr. Mohamed Lamine Ghanem
  • Director General of ANPP, Watfa Benayad
  • MOH advisor, Badra Benkedadra
  • Senior management of companies & healthcare sector representative : Saidal, Roche, Sanofi, Bayer, OMS ...
  • Senior Manager of ANPP & PCH